Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Post-stabilisation announcement

25 Sep 2013 12:40

RNS Number : 8650O
UBS Limited
25 September 2013
 



Post-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

DIRECT LINE INSURANCE GROUP PLC

Stabilisation Notice

 

 

 

UBS Limited (contact: Gareth McCartney ; telephone: 0044 20756 82227), in its capacity as Stabilisation Manager, hereby gives notice that no Stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager named in relation to the offer of the following securities.

 

The Securities:

Vendor:

Royal Bank of Scotland Group plc

Underlying shares:

Direct Line Insurance Group plc

ISIN:

GB00B89W0M42

Base size:

272.7 million shares

Offer price:

210 pence

Maximum size of over-allotment facility:

10% of the aggregate nominal amount stated above

 

In connection with its Stabilisation activities, Royal Bank of Scotland Group plc granted UBS Limited, on behalf of the Underwriters, an over-allotment option, exercisable once for a period of 30 days after the announcement of the Offer Price on 20 September 2013 which, if exercised would require Royal Bank of Scotland Group plc to sell up to 10 per cent. of the aggregate number of Offering Shares available in the Offering (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of shares effected by it during the Stabilisation period.

 

UBS Limited agreed with Royal Bank of Scotland Group plc that any over-allotment of the Offering Shares by it or any of its agents will be up to a maximum of 10 per cent. of the total number of the Offering Shares (before any exercise of the Over-allotment Option).

 

Number of Offering Shares: 272.7 million

Number of shares subject to the over-allotment option: 27.3 million

 

No stabilisation trades have or will take place.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STANKPDNKBKDOCB
Date   Source Headline
9th Apr 20146:15 pmRNSDAS - Revised State Aid Terms
8th Apr 20144:20 pmRNSBlock Listing Return
8th Apr 20144:06 pmRNSDirector/PDMR Shareholding
4th Apr 20147:00 amRNSDirectorate Change
2nd Apr 201412:55 pmRNSHolding(s) in Company
31st Mar 20145:29 pmRNSTotal Voting Rights
28th Mar 20149:39 amRNSRBSG SEC Registered Senior Notes Transaction
26th Mar 20146:19 pmRNSStabilisation Notice
25th Mar 20148:46 amRNSMorgan Stanley European Financials Conference
24th Mar 20143:53 pmRNSPublication of Final Terms
19th Mar 20141:49 pmRNSPublication of Prospectus
10th Mar 20145:51 pmRNSPublication of Prospectus
10th Mar 20144:51 pmRNSDirector/PDMR Shareholding
7th Mar 20146:24 pmRNSPublication of Registration Document
7th Mar 20141:10 pmRNSDirectorate Change
7th Mar 20141:00 pmRNSDirector/PDMR Shareholding
7th Mar 20141:00 pmRNSInvestor Meeting
28th Feb 20145:26 pmRNSTotal Voting Rights
28th Feb 20143:30 pmRNSDirector/PDMR Shareholding
28th Feb 201412:30 pmRNSAdditional Listing
27th Feb 20147:03 amRNSCompletion of Sale of Remaining Interest in DLG
27th Feb 20147:01 amRNSDirectorate Change
27th Feb 20147:01 amRNSFinal Results - Part 6 of 6
27th Feb 20147:01 amRNSFinal Results - Part 5 of 6
27th Feb 20147:01 amRNSFinal Results - Part 4 of 6
27th Feb 20147:01 amRNSFinal Results - Part 3 of 6
27th Feb 20147:01 amRNSFinal Results - Part 2 of 6
27th Feb 20147:00 amRNSFinal Results - Part 1 of 6
26th Feb 20144:57 pmRNSIntention to Sell Remaining Interest in DLG
21st Feb 20144:14 pmRNSDividend Declaration
19th Feb 20149:00 amRNSRBS Structured Retail IP&ED Business
10th Feb 201410:35 amRNSDirector/PDMR Shareholding
3rd Feb 20145:19 pmRNSCorrection: Total Voting Rights
31st Jan 20144:24 pmRNSHolding(s) in Company
31st Jan 20143:24 pmRNSTotal Voting Rights
27th Jan 20144:06 pmRNSTrading Update
16th Jan 20145:00 pmRNSHolding(s) in Company
15th Jan 201412:47 pmRNSRBS AND RBS NV ANNOUNCE CASH TENDER OFFER RESULTS
9th Jan 20141:30 pmRNSNotification of Major Interest in Shares
8th Jan 20149:13 amRNSDirector/PDMR Shareholding
7th Jan 20142:04 pmRNSSale of selected Chicago-area operations
31st Dec 201312:36 pmRNSTotal Voting Rights
31st Dec 201312:30 pmRNSDirector/PDMR Shareholding
19th Dec 20134:59 pmRNSPublication of Prospectus
17th Dec 201310:54 amRNSRBSG announces $2 billion T2 Notes transaction
16th Dec 20136:24 pmRNSEU-wide EBA Transparency Exercise
16th Dec 20135:07 pmRNSRBS cancels contingent capital facility with HMT
11th Dec 20136:13 pmRNSRBS Reaches Settlement Regarding OFAC Compliance
11th Dec 20137:00 amRNSRBS confirms Nathan Bostock to resign
9th Dec 20136:20 pmRNSALLOTMENT AND ISSUE OF NEW ORDINARY SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.